Propensity-matched analysis of outcomes after mitral valve surgery between trainees and consultants (institutional report)

Vito Domenico Bruno(Istituto Clinico Sant'Ambrogio), Hunaid A. Vohra, Raimondo Ascione(University Hospitals Bristol NHS Foundation Trust), Pierpaolo Chivasso(NIHR Bristol Cardiovascular Biomedical Research Unit), Gianni D. Angelini(Bristol Royal Infirmary), Roberto Marsico(NIHR Bristol Cardiovascular Biomedical Research Unit), Franco Ciulli(University of Bristol), Massimo Caputo, Amna Hayat(University of Bristol), Umberto Benedetto(University of Oxford)
Interactive Cardiovascular and Thoracic Surgery
November 8, 2017
10.1093/icvts/ivx368
Cited by 8

Related Papers

Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials
|The Lancet|2015|394
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients
|European Heart Journal|2016|200
Minithoracotomy vs Conventional Sternotomy for Mitral Valve Repair
|JAMA|2023|145
Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency
|The Annals of Thoracic Surgery|2001|138
Haemodynamic changes during beating heart coronary surgery with the ‘Bristol Technique’
|European Journal of Cardio-Thoracic Surgery|2001|115